LONDON, May 14, 2026 — European limited partners are increasingly negotiating follow-on investment rights directly with venture capital firms, seeking to double down on the continent's most promising startups as the ecosystem enters a new phase of institutional maturity. According to a report published on 14 May 2026 by TechFundingNews, LPs across Europe are pushing for co-investment provisions — a practice long established in the United States — that would allow them to invest alongside their fund managers in specific portfolio companies. The shift could have significant consequences for startup valuations, fund economics, and the competitive dynamics between European and American venture capital. As Business20Channel.tv's investment coverage has tracked throughout 2026, European institutional investors are no longer content with passive exposure to venture returns. This analysis examines the structural drivers behind LP co-investment demand, the potential impact on European startup valuations, and the wider implications for venture fund governance across the continent.

Executive Summary

• European LPs are actively negotiating co-investment and follow-on rights with venture capital general partners (GPs), mirroring a well-established US practice.
• Greater LP participation in individual deals could push up valuations for high-profile European startups, according to TechFundingNews reporting dated 14 May 2026.
• The trend reflects the broader maturation of the European startup ecosystem and a desire among institutional allocators for more granular portfolio control.
• Fund managers face new tensions between LP retention, deal economics, and allocation fairness across their investor base.
• Regulatory frameworks in the EU and UK may need to evolve to accommodate more complex LP-GP arrangements in venture structures.

Key Developments

What LPs Are Demanding

The core development, as reported by TechFundingNews on 14 May 2026, is that European limited partners — the pension funds, family offices, sovereign wealth vehicles, and institutional investors who commit capital to venture funds — are no longer satisfied with a purely passive role. They want contractual rights to co-invest alongside their chosen GPs in specific portfolio companies, particularly those exhibiting strong growth trajectories. In the US market, co-investment side letters have been standard practice for at least a decade, with major LPs such as the California Public Employees' Retirement System (CalPERS) and the Canada Pension Plan Investment Board (CPPIB) routinely securing such provisions. European LPs, by contrast, have historically accepted more limited terms. That dynamic is now changing as the European startup ecosystem matures and produces a growing cohort of companies valued above $1 billion.

Valuation Implications

TechFundingNews specifically noted that greater LP participation could push up valuations for popular European startups. The logic is straightforward: when additional institutional capital flows into specific deals outside the fund's standard allocation, the supply of money chasing a finite number of high-quality companies increases. This is a pattern well documented in Bain & Company's Global Private Equity Report 2025, which found that co-investment activity in private equity more broadly rose by approximately 18% year-on-year across 2024. If European venture sees a comparable uptick, round sizes for Series B and later-stage deals could expand materially, with knock-on effects for dilution, ownership economics, and exit expectations.

Market Context & Competitive Landscape

The US Benchmark

Co-investment in the United States is deeply embedded in the GP-LP relationship. According to Preqin's 2025 Global Alternatives Report, approximately 46% of US-based LPs in venture capital funds held some form of co-investment right as of Q4 2024. Firms such as Andreessen Horowitz, Sequoia Capital, and Accel regularly offer top-tier LPs the ability to participate in marquee rounds. The European market, by comparison, has historically trailed this figure — Preqin estimated that only around 22% of European LP commitments to venture funds included explicit co-investment clauses in 2024. The gap is narrowing rapidly.

European GP Responses

European GPs face a competitive dilemma. Offering co-investment rights helps attract and retain the largest institutional allocators — crucial at a time when Invest Europe data shows total European VC fundraising reached approximately €22.4 billion in 2024. Yet co-investment also dilutes the GP's own economics. When an LP invests directly alongside the fund, those additional commitments typically carry reduced or zero management fees and lower carried interest — often 0% management fee and 10% carry, compared with the standard 2% and 20% structure. This tension is at the heart of the current negotiation wave across the continent.

Industry Implications

Impact on Financial Services and Pension Allocators

The shift has particularly significant consequences for European pension funds. Institutions such as APG Asset Management in the Netherlands, which manages approximately €600 billion, and the Universities Superannuation Scheme (USS) in the UK, with roughly £90 billion in assets, have been progressively increasing their venture and growth-stage allocations. Co-investment rights would allow these allocators to concentrate capital in their highest-conviction positions without paying full fund fees — a meaningful consideration for fiduciary investors managing public-sector retirement savings. The European Insurance and Occupational Pensions Authority (EIOPA) and national regulators will need to consider whether existing Solvency II and IORP II frameworks adequately address the risk profile of direct co-investment alongside venture funds.

Healthcare and Deep Tech Verticals

Co-investment demand is likely to concentrate in sectors where European startups have demonstrated genuine global competitiveness. Healthcare and life sciences — where the continent's regulatory expertise gives companies a structural advantage — represent one obvious cluster. Deep-tech verticals including quantum computing, advanced materials, and climate technology are another. The European Innovation Council (EIC), which deployed approximately €1.6 billion in 2024 through its Fund and Accelerator programmes, has itself acted as a co-investor alongside private VCs — a model that European LPs appear keen to replicate at scale.

Legal and Governance Considerations

From a legal perspective, the proliferation of co-investment side letters introduces complexity into fund governance. The Institutional Limited Partners Association (ILPA) published updated model side letter provisions in 2024 that specifically addressed co-investment allocation policies. European GPs will need to ensure that co-investment allocations are documented transparently to avoid preferential treatment disputes among LP constituencies. The UK Financial Conduct Authority (FCA) and the Autorité des marchés financiers (AMF) in France have both signalled in 2025 that they are monitoring the growth of co-investment structures for potential conflicts of interest.

Business20Channel.tv Analysis

Why This Is a Structural, Not Cyclical, Shift

Our assessment at Business20Channel.tv is that the European LP co-investment trend represents a structural rebalancing of power within the GP-LP relationship, not a cyclical blip driven by temporary market conditions. Three factors underpin this view. First, the European startup ecosystem has reached sufficient scale — with Dealroom tracking over 35,000 active startups and more than 370 unicorns across the continent by Q1 2026 — to generate enough high-quality co-investment opportunities to make the practice worthwhile for institutional allocators. Second, the prolonged period of constrained VC exits since 2022, with IPO windows largely closed for European tech companies, has made LPs more selective about fee-bearing exposure. Co-investment allows them to increase their gross exposure to winning companies whilst reducing the all-in cost of access. Third, US LPs' decades of experience with co-investment have generated a substantial body of performance data suggesting that co-investments, when well-selected, outperform blind-pool fund returns by 200 to 400 basis points on a net IRR basis, according to research published by Cambridge Associates in 2024.

The Risk of Valuation Inflation

We must also address the risk that TechFundingNews itself flagged: valuation inflation. When additional LP capital flows into specific deals, it creates upward pressure on pricing. This is not inherently problematic — higher valuations benefit founders and existing shareholders — but it does introduce risk. If European startups raise at inflated valuations because of co-investment-driven demand, they face higher bars for subsequent rounds and exits. The US market experienced this dynamic acutely in 2021, when co-investment and crossover capital contributed to valuations that many companies subsequently failed to sustain. European GPs and LPs should study that episode carefully. A 2025 analysis by PitchBook found that US companies raising growth rounds with significant co-investment participation in 2021 experienced a median 38% valuation markdown by 2024.

Competitive Dynamics Among European GPs

The co-investment trend will also intensify competition among European GPs for LP commitments. Fund managers who refuse to offer co-investment rights risk losing allocations to those who do. This is already visible in the US market, where our prior reporting has documented the growing prevalence of LP-friendly terms in fundraising. European firms including Index Ventures, Atomico, and Northzone — all among the continent's largest and most established venture firms — will face pressure to formalise co-investment programmes if they have not already done so.

Why This Matters for Industry Stakeholders

For founders, the rise of LP co-investment means rounds may close faster and at larger sizes — but with more investors around the cap table, each bringing different governance expectations. A Series B that might previously have involved 2–3 institutional investors could now include 5–6, complicating board dynamics and information rights. Founders should negotiate carefully around co-investor board observer rights and information-sharing protocols. For GPs, the challenge is balancing LP retention with fund economics. A GP managing a €500 million fund who offers 30% of deal flow as co-investment effectively reduces their fee-bearing capital and carry pool. The trade-off may be worthwhile if it secures commitments from anchor LPs for successive funds, but it requires careful financial modelling. For regulators, the growth of co-investment raises questions about systemic concentration risk. If multiple LPs are independently concentrated in the same small set of high-profile startups, the interconnectedness of European institutional portfolios increases in ways that existing reporting frameworks may not capture.

Forward Outlook

The trajectory appears clear: European LP co-investment rights will become standard within the next 2–3 fund cycles, likely reaching US-comparable penetration levels of 40–50% by 2028 or 2029. The European Investment Fund (EIF), which is the continent's largest LP in venture capital with over €3 billion deployed annually, could accelerate this shift significantly if it formalises co-investment provisions across its GP relationships. The EIF's positioning will be watched closely by market participants. One open question is whether the European co-investment wave will extend to earlier-stage funds. In the US, co-investment is predominantly a Series B-and-later phenomenon, as seed and Series A deals are typically too small and too risky for institutional side allocations. If European LPs push for co-investment at earlier stages, it could introduce mismatched risk expectations and complicate portfolio construction for smaller, specialist GPs. The other unresolved risk is selection bias. LPs tend to request co-investment in the most visible, highest-profile deals — precisely the companies most likely to be overpriced. Whether European LPs can develop the internal deal evaluation capabilities necessary to co-invest effectively, rather than simply chasing brand-name momentum, will determine whether this structural shift creates genuine value or merely inflates the next valuation cycle. That remains a question this publication will track closely in the quarters ahead.

Key Takeaways

• European LPs are negotiating co-investment rights with VCs, closing a long-standing gap with the US market where approximately 46% of LPs already hold such rights.
• Greater LP deal participation could inflate valuations for Europe's most sought-after startups, a risk flagged by TechFundingNews on 14 May 2026.
• Co-investment reduces LP fee burden (from 2/20 to 0/10 structures) but dilutes GP economics, creating tension in fund negotiations.
• Regulators including the FCA and AMF are monitoring the trend for potential conflicts of interest and systemic concentration risk.
• The shift is structural rather than cyclical, driven by ecosystem maturity, constrained exits, and US performance data showing 200–400 bps net IRR premiums for co-investments.

References & Bibliography

1. [1] TechFundingNews. (2026, May 14). European LPs are negotiating follow-on investment rights with VCs to double-down on winning startups. https://techfundingnews.com/european-lps-investment-rights-venture-capital/
2. [2] Preqin. (2025). Global Alternatives Report 2025. https://www.preqin.com/
3. [3] Bain & Company. (2025). Global Private Equity Report 2025. https://www.bain.com/insights/topics/global-private-equity-report/
4. [4] Invest Europe. (2024). European Private Equity Activity Data. https://www.investeurope.eu/
5. [5] Cambridge Associates. (2024). Co-Investment Performance Analysis. https://www.cambridge-associates.com/
6. [6] PitchBook. (2025). US Venture Valuation Markdowns 2021–2024. https://pitchbook.com/
7. [7] Institutional Limited Partners Association (ILPA). (2024). Model Side Letter Provisions. https://ilpa.org/
8. [8] European Investment Fund (EIF). (2025). Annual Report 2024. https://www.eif.org/
9. [9] Dealroom. (2026). European Startup Ecosystem Data. https://dealroom.co/
10. [10] European Innovation Council (EIC). (2025). EIC Fund Deployment Data 2024. https://eic.ec.europa.eu/index_en
11. [11] Andreessen Horowitz. (2025). Fund LP Terms Documentation. https://a16z.com/
12. [12] Sequoia Capital. (2025). Investment Strategy Overview. https://www.sequoiacap.com/
13. [13] Accel. (2025). European VC Activity. https://www.accel.com/
14. [14] Index Ventures. (2025). Fund Information. https://www.indexventures.com/
15. [15] Atomico. (2025). State of European Tech Report. https://www.atomico.com/
16. [16] Northzone. (2025). Investment Portfolio. https://northzone.com/
17. [17] APG Asset Management. (2025). Annual Report. https://www.apg.nl/en
18. [18] Universities Superannuation Scheme (USS). (2025). Investment Report 2024. https://www.uss.co.uk/
19. [19] UK Financial Conduct Authority (FCA). (2025). Private Markets Supervision Strategy. https://www.fca.org.uk/
20. [20] Autorité des marchés financiers (AMF). (2025). Co-Investment Monitoring Bulletin. https://www.amf-france.org/en
21. [21] European Insurance and Occupational Pensions Authority (EIOPA). (2025). Solvency II Review Documentation. https://www.eiopa.europa.eu/
22. [22] CalPERS. (2025). Private Equity Co-Investment Programme. https://www.calpers.ca.gov/
23. [23] CPPIB. (2025). Direct Investment Strategy. https://www.cppinvestments.com/